BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17726570)

  • 1. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes.
    Yilmaz H; Gursoy A; Sahin M; Guvener Demirag N
    Acta Diabetol; 2007 Dec; 44(4):187-92. PubMed ID: 17726570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.
    Huang Z; Wan X; Liu J; Deng W; Chen A; Liu L; Liu J; Wei G; Li H; Fang D; Li Y
    Diabetes Technol Ther; 2013 Oct; 15(10):859-69. PubMed ID: 23991629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels.
    Zhang JP; Wang N; Xing XY; Yang ZJ; Wang X; Yang WY
    J Diabetes; 2016 Jul; 8(4):559-67. PubMed ID: 26331290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone RECORD study: glucose control outcomes at 18 months.
    Home PD; Jones NP; Pocock SJ; Beck-Nielsen H; Gomis R; Hanefeld M; Komajda M; Curtis P;
    Diabet Med; 2007 Jun; 24(6):626-34. PubMed ID: 17517066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study.
    Chen YH; Tarng DC; Chen HS
    PLoS One; 2016; 11(11):e0165750. PubMed ID: 27812149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus.
    Atamer Y; Atamer A; Can AS; Hekimoğlu A; Ilhan N; Yenice N; Koçyiğit Y
    Braz J Med Biol Res; 2013 Jun; 46(6):528-32. PubMed ID: 23802228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity.
    Sun W; Zeng C; Liao L; Chen J; Wang Y
    Curr Med Res Opin; 2016 Aug; 32(8):1389-96. PubMed ID: 27052634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.
    Gupta M; Braga MB; Verma S
    Can J Cardiol; 2008 Oct; 24(10):e65-9. PubMed ID: 18841263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.
    Alkharfy KM; Al-Daghri NM; Sabico SB; Al-Othman A; Moharram O; Alokail MS; Al-Saleh Y; Kumar S; Chrousos GP
    Cardiovasc Diabetol; 2013 Aug; 12():113. PubMed ID: 23924389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis.
    Chaudhuri A; Rosenstock J; DiGenio A; Meneghini L; Hollander P; McGill JB; Dandona P; Ilgenfritz J; Riddle M
    Diabetes Metab Res Rev; 2012 Mar; 28(3):258-67. PubMed ID: 22081557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus After 7 Years of Therapy.
    Derosa G; Tritto I; Romano D; D'Angelo A; Catena G; Maffioli P
    J Clin Pharmacol; 2019 Oct; 59(10):1391-1399. PubMed ID: 31131461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus.
    Strózik A; Stęposz A; Basiak M; Drożdż M; Okopień B
    Pharmacol Rep; 2015 Feb; 67(1):24-31. PubMed ID: 25560571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.
    Han J; Yu H; Tu Y; Pang J; Liu F; Bao Y; Yang W; Jia W
    Diabet Med; 2017 Apr; 34(4):490-499. PubMed ID: 27151271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study.
    Lee MY; Choi DS; Lee MK; Lee HW; Park TS; Kim DM; Chung CH; Kim DK; Kim IJ; Jang HC; Park YS; Kwon HS; Lee SH; Shin HK
    J Korean Med Sci; 2014 Jan; 29(1):90-7. PubMed ID: 24431911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Metformin-sulfonylurea and Metformin-acarbose Combination Therapies on Glycemic Outcomes: A Retrospective Cohort Study.
    Wafa W; Septini R; Sauriasari R
    Curr Diabetes Rev; 2022; 18(7):e031121197656. PubMed ID: 34732117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus.
    Keskin L; Yaprak B
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6813-6820. PubMed ID: 36196729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.